Ling Zhang

Ling Zhang is a scientist with a solid background in cancer immunotherapy, tumor immunology, molecular biology, cellular biology, and virology. Their expertise includes lentiviral and retroviral vector design, engineering T cells, and conducting preclinical evaluations of effective strategies for cancer immunotherapy in mouse models.

They have actively participated in multiple clinical studies related to adoptive T cell therapy. Ling Zhang is known for their excellent communication, supervisory, troubleshooting, and collaboration skills.

Ling Zhang pursued their Doctor of Medicine (MD) and Ph.D. studies at XiangYa Medical University. They have held significant roles in various organizations including being a Research Biologist at the Experimental Transplantation and Immunology Branch, a former Research Scientist at the Pediatric Oncology Branch at NIH, a former CRTA Fellow at the Surgery Branch at NIH, and a former Research Associate at USUHS.